Today: 12 March 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Gold Price Surges Past $3,800; Silver Nears 14-Year High on Fed-Cut and Shutdown Fears

Gold Blasts Above $4,100; Silver Sizzles on Fed-Cut Hopes

Gold traded near $4,118 per ounce on Oct. 24, 2025, close to its record high, after plunging 6.3% to $4,082 on Oct. 21, its steepest one-day drop since 2013. Silver fell 8.7% to $47.89 the same day, its worst loss since 2021, before rebounding to $48.7. Investors anticipate a U.S. Federal Reserve rate cut in early November. The VanEck Gold Miners ETF is up about 123% year-to-date.
24 October 2025
··
Stock Market on Edge: U.S. Futures Slide as US-China Trade War Heats Up

Stocks Surge on Cooling Inflation – Fed Cuts Loom, Experts Warn of Bubble

U.S. stocks surged after September CPI data showed inflation at 3.0%, below forecasts. The Nasdaq rose 0.9% and the S&P 500 gained 0.6% on Oct. 23, nearing record highs. Investors now fully expect a 25 bp Fed rate cut at the Oct. 28–29 meeting. Tech and AI stocks, including Nvidia and Palantir, led gains.
24 October 2025
········
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle (ORCL) Stock Surges on AI Frenzy – Trillion-Dollar Dreams in Focus

Oracle shares closed at $285.72 on Oct. 24, up 2% after rebounding from a mid-October selloff. The stock is up about 70–75% year-to-date, driven by major AI and cloud deals, including a $300 billion OpenAI contract. Oracle’s cloud backlog stands near $455 billion. Analysts have raised price targets, with consensus in the $300–$324 range.
24 October 2025
···
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple (AAPL) Stock Rockets to Record High on iPhone 17 Hype — What’s Next?

Apple shares closed at a record $262.24 on Oct. 20, then opened at $259.58 on Oct. 24, surpassing the previous high set in December 2024. Early iPhone 17 sales are 10–14% above last year, fueling speculation of a new upgrade cycle. Wall Street targets range widely, with some analysts projecting $300-plus and others warning of overvaluation. Apple reports Q4 earnings Oct. 30, with forecasts near $101 billion in revenue.
24 October 2025
···
NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy shares traded near $23.74 on Oct. 24, 2025, with very low volume and warnings of possible delisting. In September, Nevada regulators approved a new rate plan adding daily demand charges and stricter solar net-metering, drawing protests from solar groups. On Oct. 20, FERC rejected NV Energy’s requests to ease grid interconnection penalties for renewable developers.
24 October 2025
·
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr shares surged over 25% on October 24 after its two largest shareholders proposed an $18 per share buyout, valuing the company at a 51% premium to pre-offer prices. Board chair James Lu and director Ray Zage, controlling about 60% of shares, submitted the non-binding bid and say financing is secured. Grindr’s board formed a special committee to review the offer. Trading volume spiked to nearly 6 million shares.
24 October 2025
··
Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health stock surged nearly 18% to about $3.79 on Oct. 24, with trading volume exceeding 15 million shares, far above its average. The price broke past both its 50-day and 200-day moving averages. Zacks upgraded the stock to Buy on Oct. 23, but overall analyst consensus remains Hold, with a 12-month price target averaging $4.03. Short interest stands at roughly 12.9% of float.
24 October 2025
·
Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union shares traded near $8.15 on Oct. 23, up 0.4% after Q3 results beat adjusted EPS estimates. Q3 revenue was $1.03 billion, flat year-over-year, with digital and consumer services driving growth. WU agreed to buy Intermex for $500 million and struck new fintech partnerships. Analysts remain cautious, citing competition and execution risks despite a high dividend yield.
24 October 2025
··
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva shares surged 92% intraday Oct. 15 after its VCN-01 therapy met primary endpoints in a Phase 2b pancreatic cancer trial, then fell back following a $4 million equity raise. Median survival in a two-dose subgroup reached 14.8 months versus 11.6 for chemo alone. The company held $12.1 million cash as of June 30, 2025, funding operations into early 2026. Expanded trial results will be presented at ESMO Oct. 20.
24 October 2025
·
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet Stock Skyrockets to Record High, Nears $3 Trillion on AI Boom & Earnings Hype

Alphabet Inc. hit a record near $260 per share on Oct. 24, pushing its market value to about $3.1 trillion. The stock rebounded after a volatile week, buoyed by a breakthrough quantum computing announcement and a major cloud deal with Anthropic. Analysts raised price targets, with several now above $290. Alphabet reports Q3 earnings Oct. 29.
24 October 2025
···
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria shares plunged about 67% in after-hours trading Oct. 20 after its lead drug BNC210 failed a Phase 3 trial for social anxiety disorder. The company halted its social anxiety program, began a strategic review, and said it would cut spending. NEUP stock dropped from $15.40 to near $4.05 before rebounding to $6.70 by Oct. 24. Neuphoria reported $14.2 million in cash as of June 30 and maintains a partnership with Merck.
24 October 2025
·
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical stock plunged about 75% to $3.27 by mid-day Oct. 24, after hitting a 52-week high of $13.68 the previous day. The selloff followed an SEC filing authorizing up to 18 million new shares, raising dilution fears. The company recently reported 207% Q2 revenue growth and completed a $19.5 million IPO in September. Analysts cite uncertainty over future growth and dilution.
24 October 2025
·
General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics reported Q3 2025 revenue of $12.91 billion, up 10.6% year-over-year, and EPS of $3.88, beating forecasts. Gulfstream jet deliveries rose to 39 from 28, driving a 30% jump in aerospace revenue. The company ended the quarter with a $167.7 billion backlog and won major new defense contracts. GD shares climbed to around $353 after hours, up 27% year-to-date.
24 October 2025
···
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis announced FDA 510(k) clearance for its PENFS device to treat adult functional dyspepsia on Oct. 24, marking the first approved therapy for this condition. NRXS shares rose to $3.82 on Oct. 23 and traded higher pre-market after the news. The company recently raised $5 million and expanded insurance coverage to 53 million lives. Q2 revenue grew 46% year-over-year; analyst sentiment remains mixed.
24 October 2025
··
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies closed a $14.2 billion acquisition of Mr. Cooper Group on Oct. 1, the largest mortgage merger to date. RKT stock trades near $17, up about 80% year-to-date but below its early October high of $22.56. Shares have rallied 50% since the merger was announced in March, with short interest at 57%. Q3 earnings are due Oct. 30, with analysts expecting EPS of $0.04, down 50% year-over-year.
24 October 2025
··
American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines raised its 2025 profit outlook to $0.65–$0.95 EPS, up from a prior forecast of up to a $0.20 loss. Shares jumped 6% to $12.77 on Thursday. Third-quarter revenue hit a record $13.7 billion, while adjusted earnings showed a smaller-than-expected loss at -$0.17 per share. Premium cabin sales and cost controls offset flat overall revenue.
24 October 2025
··
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Denison Mines (DNN) Rides Uranium Boom as Wheeler River Advances – What’s Next?

Denison Mines shares more than doubled in 2025, reaching multi-year highs as uranium prices hit $80–$83 per pound. The company’s Wheeler River project secured key provincial permits and awaits a federal license by December. Denison restarted uranium production for the first time in 15 years and raised $345 million for growth. All five brokerages covering Denison rate the stock a “Buy” or “Outperform.”
24 October 2025
··
1 … 211 212 213 214 215 … 358

Stock Market Today

  • Intuitive Surgical's da Vinci 5 Secures FDA Approval for Cardiac Surgery Expansion
    March 12, 2026, 1:56 PM EDT. Intuitive Surgical (ISRG) gained FDA clearance for cardiac procedures using its da Vinci 5 robotic platform, marking a strategic step into complex heart surgeries. While current cardiac uses are modest, with around 17,000 procedures performed globally on prior models, ISRG estimates a $160,000 procedure annual market for da Vinci 5 in cleared regions like the U.S. and South Korea. Growth hinges on surgeon training, dedicated cardiac instruments, and clinical evidence over several years. This cautious but steady approach aims to broaden Intuitive's total addressable market by integrating advanced robotic tools in cardiac care. Peer company Zimmer Biomet (ZBH) also advances its ROSA robotic system in orthopedics, reflecting a broader industry push toward surgical robotics.

Latest article

Gold Price Today Falls Despite Iran Risk as Dollar Firms, Fed Cut Bets Fade

Gold Price Today Falls Despite Iran Risk as Dollar Firms, Fed Cut Bets Fade

12 March 2026
Gold prices fell 0.3% Thursday, with spot bullion at $5,159.04 an ounce as a stronger dollar and reduced expectations for U.S. rate cuts outweighed safe-haven demand. U.S. consumer prices rose 0.3% in February, keeping pressure on the Federal Reserve to hold rates higher. Toronto’s materials sector dropped 1.7% as gold miners declined. Futures now suggest the first Fed rate cut in September.
Kingfisher Plc Share Price Slides Ahead of Full-Year Results Despite Fresh Broker Support

Kingfisher Plc Share Price Slides Ahead of Full-Year Results Despite Fresh Broker Support

12 March 2026
Kingfisher Plc shares closed down 1.8% at 307.6 pence on Thursday, extending a five-day slide to 10.4% ahead of full-year results due March 24. The drop comes as UK housing demand weakens and energy prices climb after attacks on Iraqi tankers. Broker sentiment remains mixed, with recent upgrades offset by cautious targets. Kingfisher’s analyst page shows three buys, 10 holds, and three sells.
Go toTop